Abstract
Iran is a country with the highest rate of opioid addiction in the world. The most commonly used opioid in Iran is opium, and methadone is in second place. The trend of drug use has changed from opium to methadone from 2006 to 2011. Presence of a large number of addicted people and methadone maintenance therapy clinics make methadone readily available in Iran. Therefore, evaluation of the epidemiological characteristic of methadone toxicity and its effects on the heart is essential. In This cross-sectional, retrospective, descriptive, analytical study all patients with methadone or opium toxicity who had been admitted to Vasei hospital, Sabzevar, Iran, during the years 2015 and 2016 were included, and their records were evaluated. Demographic data, addiction history, underlying diseases, and the outcome of admission were recorded. Then, corrected QT interval (QTc) of the first ECG of the patients after admission was evaluated. The Majority of toxicities occurred in those above 30 years of age (71.4%), who lived in cities (62.8%), and were married (69.2%). A positive history of addiction was considerably higher in the opium group (72.3% versus 43.3%). There was no significant difference regarding QTc prolongation between patient...Continue Reading
References
Dec 1, 1993·British Journal of Pharmacology·M K PugsleyM J Walker
Oct 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Alexander N KatchmanSteven N Ebert
Jan 25, 2003·American Journal of Physiology. Heart and Circulatory Physiology·James A ColesPaul A Iaizzo
Jun 25, 2003·Pharmacotherapy·Mori J KrantzPhilip S Mehler
Dec 21, 2004·European Addiction Research·Icro MaremmaniAlessandro Tagliamonte
Oct 20, 2005·Pharmacotherapy·Mori J KrantzJulia H Arnsten
Jun 28, 2006·Archives of Internal Medicine·Georg B EhretJules A Desmeules
Jan 16, 2007·Addiction·Einat PelesMiriam Adelson
May 28, 2009·Addiction·Christina WallnerPeter Hermann
Feb 10, 2010·Circulation·Barbara J DrewUNKNOWN American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, the Council on Cardiovascular
Apr 24, 2012·Environmental Toxicology and Pharmacology·Hamid Najafipour, Siyavash Joukar
Jul 1, 2012·Anesthesiology and Pain Medicine·Mahdi Najafi, Mehrdad Sheikhvatan
Dec 4, 2013·Cardiovascular Toxicology·Hossein Hassanian-MoghaddamMaryam Taherkhani
May 9, 2014·Cardiovascular Toxicology·Davood FarsiShahriar Zehtabchi
Jul 6, 2014·Journal of Research in Pharmacy Practice·Fatemeh TaheriZiba Farajzadegan
Mar 6, 2015·International Journal of High Risk Behaviors & Addiction·Sharareh EskandariehMohammad Bagher Saberi-Zafarghandi
Dec 27, 2016·SpringerPlus·Samira AlinejadOmid Mehrpour
Aug 13, 2017·Basic & Clinical Pharmacology & Toxicology·Samira AlinejadOmid Mehrpour
Oct 19, 2017·Electronic Physician·Amir GhaderiMorad Rasouli-Azad
Oct 28, 2017·The Journal of Nervous and Mental Disease·Joseph WestermeyerTegan Batres-Y-Carr
Nov 28, 2017·Substance Use & Misuse·Alireza AmirabadizadehOmid Mehrpour
Jan 6, 2018·Cancer Treatment Reviews·Carmela CoppolaNicola Maurea
Mar 28, 2018·Journal of Clinical Medicine Research·Karuppiah ArunachalamPaari Dominic
Jun 13, 2018·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Amy J SchwinghammerBrent A Hall
Jul 10, 2018·BMJ Open·Camilla Schade HansenAnnmarie Touborg Lassen
Jul 19, 2018·Cardiovascular Toxicology·Mehdi SheibaniHossein Hassanian-Moghaddam
Citations
Nov 20, 2019·Journal of Clinical Pharmacology·Munveer ThindJ Rick Turner
Apr 19, 2020·Substance Abuse Treatment, Prevention, and Policy·Samaneh NakhaeeOmid Mehrpour
Jun 7, 2020·Substance Abuse Treatment, Prevention, and Policy·Mehdi MoradinazarMehdi Mirzaei-Alavijeh
Apr 21, 2020·Frontiers in Pharmacology·Mohammad Sadeghi BimorghHamid Reza Banafshe
Oct 21, 2020·Phytotherapy Research : PTR·Samira Abbaszadeh-MashkaniAmir Ghaderi
Nov 21, 2020·Journal of Addictive Diseases·Bahadir DemirAbdurrahman Altindag
Apr 9, 2021·Peptides·Richard J Bodnar